Top of page
Lawyers

Richard D. Truesdell, Jr.

Lawyers

Filters

Celgene $3 Billion Notes Offering
Davis Polk advised the joint book-running managers on an SEC-registered offering by Celgene Corporation of $750 million aggregate principal amount of 2.750% senior notes due 2023, $1…
REV Group, Inc. $272.5 Million Secondary Offering
Davis Polk advised REV Group, Inc. and certain selling stockholders in connection with an SEC-registered secondary offering of 10,000,000 shares of common stock by such selling stockholders…
Deciphera Pharmaceuticals Initial Public Offering
Davis Polk advised the underwriters in connection with an initial public offering of 7,500,000 shares of common stock of Deciphera Pharmaceuticals, Inc., at $17.00 per share, for total…
Back to top